Literature DB >> 24724964

Findings from the implementation of a validated readmission predictive tool in the discharge workflow of a medical intensive care unit.

Uchenna R Ofoma1, Subhash Chandra, Rahul Kashyap, Vitaly Herasevich, Adil Ahmed, Ognjen Gajic, Brian W Pickering, Christopher J Farmer.   

Abstract

RATIONALE: Provider decisions about patients to be discharged from the intensive care unit (ICU) are often based on subjective intuition, sometimes leading to premature discharge and early readmission. The Stability and Work Load Index for Transfer (SWIFT) score, as a risk stratification tool, has moderate ability to predict patients at risk of ICU readmission.
OBJECTIVES: To describe findings following the incorporation of the SWIFT score into the discharge workflow of a medical ICU.
METHODS: The study involved 5,293 consecutive patients discharged alive from the medical ICU of an academic medical center. The SWIFT score and associated percentage risk for readmission were incorporated into daily rounds for purpose of discharge decision-making. We measured readmission rates before and after implementation and observed changes in provider discharge decisions for individual patients after SWIFT discussions.
MEASUREMENTS AND MAIN RESULTS: Baseline (n = 1,906) and implementation (n = 1,938) cohorts differed with respect to APACHE III scores (P = 0.03). In the implementation cohort, 26.2% of subjects had SWIFT scores greater than 15 and thus were predicted to have a higher risk of unplanned readmissions. In this high-risk group, 25% had SWIFT discussed in their discharge planning. There was modification of provider discharge decisions in 108 (30%) of cases in which the SWIFT was discussed. SWIFT score values above a prespecified cutoff of 15 were associated with physician tendency to prolong ICU stay or to discharge to a monitored setting (P < 0.001). There was no difference in 24-hour or 7-day readmission rates between the baseline and implementation cohorts (1.9 vs. 2.4%, P = 0.24; 6.5 vs. 7.4%, P = 0.26, respectively) even after adjustment for severity of illness.
CONCLUSIONS: Using the SWIFT score as an adjunct to clinical judgment, physicians modified their discharge decisions in one-third of subjects. Introducing such tools into the discharge workflow may present change management challenges that limit the evaluation of their impact on readmission rates and other relevant ICU outcomes.

Entities:  

Keywords:  care transitions; quality; readmissions; risk stratification

Mesh:

Year:  2014        PMID: 24724964     DOI: 10.1513/AnnalsATS.201312-436OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  5 in total

1.  Automatic quality improvement reports in the intensive care unit: One step closer toward meaningful use.

Authors:  Mikhail A Dziadzko; Charat Thongprayoon; Adil Ahmed; Ing C Tiong; Man Li; Daniel R Brown; Brian W Pickering; Vitaly Herasevich
Journal:  World J Crit Care Med       Date:  2016-05-04

2.  Does the implementation of a novel intensive care discharge risk score and nurse-led inpatient review tool improve outcome? A prospective cohort study in two intensive care units in the UK.

Authors:  Jez Fabes; William Seligman; Carolyn Barrett; Stuart McKechnie; John Griffiths
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

3.  A qualitative exploration of the discharge process and factors predisposing to readmissions to the intensive care unit.

Authors:  Uchenna R Ofoma; Yue Dong; Ognjen Gajic; Brian W Pickering
Journal:  BMC Health Serv Res       Date:  2018-01-05       Impact factor: 2.655

4.  Explainable time-series deep learning models for the prediction of mortality, prolonged length of stay and 30-day readmission in intensive care patients.

Authors:  Yuhan Deng; Shuang Liu; Ziyao Wang; Yuxin Wang; Yong Jiang; Baohua Liu
Journal:  Front Med (Lausanne)       Date:  2022-09-28

5.  Importance of the National Early Warning Score (NEWS) at the time of discharge from the intensive care unit

Authors:  Cihangir Doğu; Güvenç Doğan; Selçuk Kayir; Özgür Yağan
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.